5 Best Canadian Stocks To Buy Right Now

Enbridge Energy Partners LP (EEP) is a midstream operator that generates a steady stream of what management describes as ��tility-like��revenue.

Spun out from Canadian energy giant Enbridge (ENB), the MLP is the largest transporter of crude oil into the US from western Canada. The firm also operates highest-capacity pipeline serving the Bakken Shale, a prolific crude-oil play in North Dakota.

The partnership owns and operates roughly 6,500 miles of liquids transportation and gathering pipelines, as well as 11,400 miles of natural-gas pipelines.

Attached to these pipelines are storage facilities that can hold up to 39.4 billion barrels of liquid hydrocarbons and extensive gas processing and treatment capacity.

5 Best Canadian Stocks To Buy Right Now: Enbridge Inc(ENB)

Enbridge Inc. engages in the transportation and distribution of crude oil and natural gas primarily in Canada and the United States. Its Liquids Pipelines segment operates common carrier and contract crude oil, natural gas liquids (NGLs), and refined products pipelines and terminals. The company?s Gas Distribution segment distributes natural gas to residential, commercial, and industrial customers primarily in central and eastern Ontario, northern New York State, Quebec, and New Brunswick. Enbridge?s Gas Pipelines, Processing and Energy Services segment invests in natural gas pipelines, processing and green energy projects, and commodity marketing businesses, as well as performs commodity storage, transport, and supply management services. Its Sponsored Investments segment transports crude oil and other liquid hydrocarbons through common carrier and feeder pipelines, as well as transports, gathers, processes, and markets natural gas and NGLs; operates a crude oil and liqui ds pipeline and gathering system; and owns a 50% interest in the Canadian portion of Alliance Pipeline and partial interests in various green energy investments. The company was formerly known as IPL Energy Inc. and changed its name to Enbridge Inc. in October 1998. Enbridge Inc. was founded in 1949 and is headquartered in Calgary, Canada.

Advisors' Opinion:

• [By Dan Caplinger]

  Energy has also held the Canadian economy back, with challenges hampering the potential growth in the industry. Enbridge (NYSE: ENB  ) and TransCanada, for instance, both have huge opportunities to capitalize on prospective new pipelines, yet environmental concerns haven't allowed the companies to work as quickly as they might otherwise to build out energy-transportation infrastructure for hard-to-reach production areas.

• [By Arjun Sreekumar]

  Consider the rupture of an Enbridge (NYSE: ENB  ) pipeline, which discharged roughly a million gallons of bituminous crude into Michigan's Kalamazoo River in June 2010. Though three years have passed, the cleanup effort still isn't over. Enbridge employees and state and federal environmental crews continue to test the river, where sheen and clumps of oil still linger. The company reported a 4% year-over-year decrease in its first-quarter net income, partially because of the escalation of cleanup costs related to the spill, which are now approaching a whopping $1 billion.

• [By Tyler Crowe]

  One midstream company is wise to this idea and has plans to be the connection. Enbridge's (NYSE: ENB  ) Alberta Clipper and Southern Lights project currently delivers about 180,000 barrels per day of condensate from Chicago to Alberta. The company plans to expand that capacity to 275,000 bpd to accommodate the needs of Canadian oil sands and the abundant amount of condensate from places like the Utica.

• [By Tyler Crowe]

  Today, many newly discovered unconventional sources are very light, sweet, and easy to refine. Since our Gulf Coast refineries are still geared toward heavy, sour crudes, we will continue to import that grade to use in these facilities. In fact, one type of crude oil that is strikingly similar to�Venezuelan�and Mexican crudes is Canadian oil sands. Canadian oil sands are in�desperate�need of refineries capable of treating this heavy mix, and Gulf of Mexico refineries are just the type of refinery these crudes need. This is the driving force for Canadian pipeline companies TransCanada (NYSE: TRP  ) and Enbridge (NYSE: ENB  ) expanding their takeaway capacity to the Gulf through the Keystone XL and the Trunkline conversion, respectively.

5 Best Canadian Stocks To Buy Right Now: Kinross Gold Corporation(KGC)

Kinross Gold Corporation, together with its subsidiaries, engages in mining and processing gold ores. It also involves in the exploration and acquisition of gold bearing properties. The company?s gold production and exploration activities are carried out principally in the Americas, Africa, and the Russian Federation. As of December 31, 2010, its proven and probable mineral reserves were 62.4 million ounces of gold, 90.9 million ounces of silver, and 1.4 billion pounds of copper. The company was founded in 1972 and is based in Toronto, Canada.

Advisors' Opinion:

• [By Patricio Kehoe]

  Making smart investments in the gold industry is not an easy task. Firms suffer from different problems, such as high cash costs which leave them exposed to declining gold prices, and difficulties while executing expansion projects. Agnico Eagle Mines (AEM) and Kinross Gold (KGC) are two such gold miners, which not only face different challenges, but very different outlooks.

• [By Rich Duprey]

  Of course, not all of Barrick's problems are of its own making. Other major miners, such as Vale� (NYSE: VALE  ) , Rio Tinto (NYSE: RIO  ) , and BHP Billiton, are selling mines or considering doing so to shore up finances and concentrate on core operations. And gold has been in a rut that's caused some of the best miners from�Yamana Gold (NYSE: AUY  ) to Kinross Gold (NYSE: KGC  ) to lose 25% or more of their value in the past month. A week ago, gold suffered its largest one-day drop in three decades.

Hot Value Companies To Own For 2014: Valeant Pharmaceuticals International Inc(VRX)

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. It offers Wellbutrin XL to treat depressive disorders; Xenazine to treat chorea associated with Huntington?s disease; CeraVe to rebuild and repair skin barrier; and Kinerase, a cosmetic product. The company also provides Zovirax ointment to treat initial genital herpes; Xerese to treat recurrent herpes labialis; Elidel to treat atopic dermatitis; and Acanya and Atralin gels to treat acne vulgaris. In addition, it offers Cesamet to treat nausea and vomiting associated with cancer chemotherapy; Tiazac XC to treat hypertension and angina; Wellbutrin to treat depressive illness; Sublinox to treat insomnia; and Lodalis to treat hypercholesterolemia. Further, the company provides Cold-FX to strengthen immune system; Duromine/Metermine for weight loss; Difflam to treat sore throa ts; and Duro-Tuss and Rikodeine to treat dry and chesty cough, as well as various branded generics for treatments, including antibiotics, treatments for cardiovascular and neurological diseases, antifungal medications, and diabetic therapies. Additionally, it offers Bisocard to treat hypertension and angina pectoris; Flucinar, a corticosteroid ointment; and Sachol mouth ulcer gel; Bedoyecta to treat neurotic pain; M.V.I., a hospital dietary supplement for trauma and burns; Tandene to treat fever and headache; Melleril to treat anxiety and depression; and products for therapeutic classes, such as vitamin deficiency, antibacterials, and dermatology. It markets its products in the United States, Canada, Australia, New Zealand, Europe, Latin America, southeast Asia, and South Africa. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1960 and is headquartered in M ississauga, Canada.

Advisors' Opinion:

• [By CanadianValue]

  On the acquisition front, Valeant (VRX) was involved in several transactions including PharmaSwiss, Sanitas, Ortho Dermatologics, Dermik, and iNova. The PharmaSwiss and Sanitas acquisitions should increase Valeant�� European business to well over $600 million in revenues in 2012, which would put Europe at close to 20% of the total business. Ortho Dermatologics and Dermik will help Valeant become one of the leading dermatology companies in the world with over $1 billion in revenues. iNova increased Valeant�� presence in Australia and helped it establish footholds in South Africa and Southeast Asia. Management is optimistic that the new positions in Southeast Asia, South Africa and Russia represent future growth platforms for Valeant.

• [By Dan Caplinger]

  Finally, outside the Dow, Valeant Pharmaceuticals (NYSE: VRX  ) has soared another 9%, adding to a 13% jump Friday after the company followed through on its rumored buyout of privately held Bausch & Lomb. The $8.7 billion deal will give Valeant a big competitive edge in the eye-care market, which looks increasingly promising as an aging population faces potential vision problems.

• [By Ben Levisohn]

  While the Paladin deal expands potential growth areas for the company, Endo�� business development focus remains on the heavily fragmented US market, where the company believes it can create the most value by operating acquired assets more efficiently. Management sees a robust pipeline of potential future deals and does not necessarily view other companies that benefit from a low tax rate [(Actavis (ACT), Perrigo (PRGO), Valeant Pharmaceuticals International (VRX))] as direct competitors for the assets it is targeting. We believe business development is likely to accelerate post the Paladin deal and the re-domicile to Ireland, and view Endo as in the early stages of its consolidation strategy…And with greater than $2 billion in capacity to do deals, we expect business development to accelerate.

• [By David Williamson]

  Though many excited traders had hoped to see the bidding war continue between Valeant Pharmaceuticals (NYSE: VRX  ) and Merz over Obagi Medical Products (NASDAQ: OMPI  ) and a subsequent run-up in the stock price of the smaller dermatological products maker, Merz has now walked away from the table, leaving the highly acquisitive Valeant the victor. In this video, Motley Fool health care analyst David Williamson gives us some background on these companies and tells us how Valeant plans to profit from the deal, and describes for investors why this is a win both for Obagi and for Valeant.

5 Best Canadian Stocks To Buy Right Now: Vanguard Natural Resources LLC(VNR)

Vanguard Natural Resources, LLC, through its subsidiaries, engages in the acquisition and development of oil and natural gas properties in the United States. Its properties are located in the southern portion of the Appalachian Basin, primarily in southeast Kentucky and northeast Tennessee; the Permian Basin, primarily in west Texas and southeastern New Mexico; and south Texas. As of December 31, 2010, the company had estimated proved reserves of 69.3 million barrels of oil equivalent, as well as working interests in 2,270 net productive wells. Vanguard Natural Resources, LLC was founded in 2006 and is based in Houston, Texas.

Advisors' Opinion:

• [By Matt DiLallo]

  Vanguard Natural Resources (NASDAQ: VNR  )
  Clocking in at No. 2 with a five-year compound annual growth rate of 172% is Vanguard Natural Resources. The company started with just 67 billion cubic feet equivalent of mainly natural gas reserves in Kentucky and Tennessee back in 2007. Today, the company has 175 million barrels of oil equivalent reserves spread across nine operating areas.

• [By Matt DiLallo]

  The problem, though, is finding that right deal at the right price. Vanguard Natural Resources (NASDAQ: VNR  ) for example reviews about 150 acquisition candidates each year and whittles that down to about 50 that are evaluated more deeply. Since its IPO, the company has only closed 18 transaction as few meet the stringent requirements needed to move the needle. It's a similar story at BreitBurn which screened 500 opportunities last year but just closed seven deals for about $600 million.�

• [By Matt DiLallo]

  The only other option to fund these capital needs is to form foreign joint ventures, which could jeopardize our dream of energy independence, or simply unload mature oil and gas assets. That last option has opened up a hidden opportunity for upstream oil and gas MLPs such as LINN Energy (NASDAQ: LINE  ) and�Vanguard Natural Resources (NASDAQ: VNR  ) to consolidate these mature producing properties.

• [By Matthew DiLallo]

  Oil and natural gas producer Vanguard Natural Resources (NASDAQ: VNR  ) likes to go against the grain. While most of its peers have been focused on acquiring or developing oil-rich assets, Vanguard has been shopping in the clearance isle and stocking up on natural gas. It's a move that could pay off handsomely in a couple of years as the supply and demand balance for natural gas begins to shift.

5 Best Canadian Stocks To Buy Right Now: Mobile TeleSystems (MBT)

Mobile TeleSystems OJSC, together with its subsidiaries, provides telecommunications services primarily in the Russian Federation, Ukraine, Uzbekistan, Armenia, and Belarus. The company provides a range of mobile and fixed line voice and data telecommunications services, including transmission, broadband, pay-TV, and various value-added services; and sells equipment and accessories. It also offers network access services, including mobile cellular voice and data communication services; automatic roaming services; GPRS and Internet access services; and 3G technology. In addition, the company�s services include the design, construction, and installation of local voice and data networks capable of interconnecting with fixed line operators; installation and maintenance of cellular payphones; lease of digital communication channels; and provision of access to open computer databases and data networks, including the Internet, as well as video conferencing, and fixed, local, and long-distance telecommunications services. Its value-added services comprise call divert/forwarding, caller ID and anti-caller ID display, conference calling, WiFi, GPRS, intelligent call assistant, APN remote access point, fixed mobile convergence, enhanced data rates for GSM Evolution, call barring, SMS, mobile office, voicemail, mobile banking, wireless application protocol, MTS-Connect, SIM-browser, point-to-point transfer, unstructured supplementary services data, downlink packet access, mobile TV, call waiting, MMS, ring tones, missed call alert, itemization of monthly bills, information and directory, international access, WEB and WAP portal, customer care system, ring back tone, collect call, and location-based services. As of December 31, 2011, the company had a mobile subscriber base of approximately 101.14 million. It has a strategic partnership with Vodafone. The company was founded in 1993 and is headquartered in Moscow, the Russian Federation.

Advisors' Opinion:

• [By Dan Radovsky]

  VimpleCom, a joint venture of Norwegian telecom Telnor and the Russian Alfa Group, operates under the BeeLine brand in Russia. BeeLine has joined the two other ex-iPhone carrying Russian heavyweight mobile carriers, Megafon and Mobile TeleSystems (NYSE: MBT  ) , and not renewed its iPhone contract with Apple.

• [By Eric Lam]

  Manitoba Telecom (MBT) gained 5.7 percent to C$33.93 after selling its Allstream fiber network business to Accelero Capital Holdings for C$520 million. The company will use the cash to invest in new wireless spectrum and improve the speed of its existing networks, Manitoba Telecom said in a statement.

• [By Rich Smith]

  Over in Russia, market-leading cell phone provider Mobile TeleSystems (NYSE: MBT  ) has just confirmed that, as of 2012, it no longer sells Apple's (NASDAQ: AAPL  ) new iPhone models to its customers directly. The company does still stock, and sell, some older iPhone models. But for iPhone5 and on up, MTS now answers phone calls from Apple with a Spasibo, ne nada. ("Thanks, but no thanks.")